Dr Agarwal's Hea

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE943P01029
  • NSEID: AGARWALEYE
  • BSEID: 544350
INR
499.00
-4.25 (-0.84%)
BSENSE

Dec 05

BSE+NSE Vol: 39.1 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Net Sales
986.11
820.06
650.58
Other Operating Income
0.00
0.00
0.00
Total Operating income
986.11
820.06
650.58
Raw Material Cost
0.40
0.50
0.55
Purchase of Finished goods
94.28
88.88
71.06
(Increase) / Decrease In Stocks
-0.84
-6.94
-5.95
Employee Cost
194.64
155.86
119.50
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
264.57
227.03
178.84
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
169.06
144.14
120.38
Total Expenditure (Excl Depreciation)
722.11
609.47
484.38
Operating Profit (PBDIT) excl Other Income
264.00
210.59
166.20
Other Income
21.32
17.88
12.12
Operating Profit (PBDIT)
285.32
228.47
178.32
Interest
47.25
55.43
45.84
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
238.07
173.04
132.48
Depreciation
130.81
112.69
82.10
Profit Before Tax
107.26
60.35
50.37
Tax
32.71
20.79
19.24
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
74.55
39.56
31.13
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
74.55
39.56
31.13
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-14.81
-11.00
-6.65
Other related items
0.00
0.00
0.00
Consolidated Net Profit
59.74
28.56
24.49
Equity Capital
31.62
30.76
9.33
Face Value
1.0
1.0
10.0
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
1.89
0.93
26.25
Diluted Earnings per share
1.88
1.0
33.38
Operating Profit Margin (Excl OI)
26.77%
25.68%
25.55%
Gross Profit Margin
24.14%
21.1%
20.36%
PAT Margin
7.56%
4.82%
4.78%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 20.25% vs 26.05% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is 109.17% vs 16.62% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 25.36% vs 26.71% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is -14.76% vs 20.92% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Dr Agarwal's Hea With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
986.11
1,832.30
-846.19
-46.18%
Other Operating Income
0.00
0.00
0.00
Total Operating income
986.11
1,832.30
-846.19
-46.18%
Raw Material Cost
0.40
0.00
0.40
Purchase of Finished goods
94.28
395.20
-300.92
-76.14%
(Increase) / Decrease In Stocks
-0.84
-16.00
15.16
94.75%
Employee Cost
194.64
325.50
-130.86
-40.20%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
264.57
0.00
264.57
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
169.06
731.00
-561.94
-76.87%
Total Expenditure (Excl Depreciation)
722.11
1,435.70
-713.59
-49.70%
Operating Profit (PBDIT) excl Other Income
264.00
396.60
-132.60
-33.43%
Other Income
21.32
11.30
10.02
88.67%
Operating Profit (PBDIT)
285.32
407.90
-122.58
-30.05%
Interest
47.25
77.60
-30.35
-39.11%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
238.07
330.30
-92.23
-27.92%
Depreciation
130.81
119.50
11.31
9.46%
Profit Before Tax
107.26
210.80
-103.54
-49.12%
Tax
32.71
53.50
-20.79
-38.86%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
74.55
157.30
-82.75
-52.61%
Extraordinary Items
0.00
-0.30
0.30
100.00%
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
74.55
157.00
-82.45
-52.52%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-14.81
-11.50
-3.31
-28.78%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
59.74
145.50
-85.76
-58.94%
Equity Capital
31.62
80.00
-48.38
-60.47%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
1.89
3.64
-1.75
-48.08%
Diluted Earnings per share
1.88
3.64
-1.76
-48.35%
Operating Profit Margin (Excl OI)
26.77%
21.64%
0.00
5.13%
Gross Profit Margin
24.14%
18.03%
0.00
6.11%
PAT Margin
7.56%
8.58%
0.00
-1.02%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 986.11 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 20.25% vs 26.05% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 59.74 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 109.17% vs 16.62% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 264.00 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 25.36% vs 26.71% in Sep 2024

Half Yearly - Interest
Interest 47.25 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -14.76% vs 20.92% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.77%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024